Earlier Anti-Tumor Necrosis Factor Therapy of Crohn’s Disease Correlates with Slower Progression of Bowel Damage

INTRODUCTION: Crohn’s disease (CD) follows a relapsing and remitting course incurring cumulative bowel damage over time. The question of whether or not the timing of the initiating biologic therapy affects long-term disease progression remains unanswered. Herein, we calculated rates of change in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dig Dis Sci
Autors principals: Panchal, Hinaben, Wagner, Mathilde, Chatterji, Manjil, Taouli, Bachir, McBride, Russell, Patterson, Jeromy R., Ungaro, Ryan, Dubinsky, Marla, Cho, Judy, Sachar, David B.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049096/
https://ncbi.nlm.nih.gov/pubmed/30607690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-018-5434-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars